Regional News

Dreams Live on: Soul APP Creates Talent Show with Gostar Bustar for Korean College Students

SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- "It is Soulstar that gave me the courage to achieve my dream during this tough time." said by Shin Juyeong, the champion of Soulstar. Lately social media Soul App has launched a Soulstar talent show in collaboration with variety entertainment Gostar Bustar, ...

2022-01-06 22:47 2641

DEEP Robotics' Jueying Lite2 Robot Dog Makes Its Debut at CES 2022

HANGZHOU, China, Jan. 6, 2022 /PRNewswire/ -- DEEP Robotics exhibited its intelligent quadruped robot Jueying Lite2 with its partner Alisys at CES 2022, the tech industry's annual trade show held this year inLas Vegas on January 5-7, 2022, showcasing cutting-edge robotics technologies. Jueying Li...

2022-01-06 22:30 2782

WorkJam Expands Leadership to Accelerate Global Growth With Appointment of CHRO, CMO, and EMEA Managing Director

The newly appointed Chief Human Resources Officer, Chief Marketing Officer, and EMEA Managing Director bring to WorkJam proven expertise driving global expansion, brand excellence, and developing employee experiences internally and externally MONTREAL, Jan. 6, 2022 /PRNewswire/ -- WorkJam, the ...

2022-01-06 22:03 2515

Wondershare Updates PDFelement for Mobile with New Conversion Features

VANCOUVER, British Columbia, Jan. 6, 2022 /PRNewswire/ -- Wondershare Technology has announced extensive file conversion and other feature additions as it rolls outPDFelement for iOS Version 2. The new iteration introduces several useful features such as PDF convers...

2022-01-06 22:00 2918

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

SEOUL, South Korea, Jan. 6, 2022 /PRNewswire/ -- LISCure Biosciences Inc., a leading biotech focused on microbial-based therapeutics, announced that it has executed a research collaboration agreement with Mayo Clinic for new drug development for rare liver diseases. LISCure has been conducting j...

2022-01-06 22:00 2367

Farmmi Receives Government's Leading Enterprise Designation and Monetary Award

LISHUI, China, Jan. 6, 2022 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier inChina, today announced the Company's subsidiary Zhejiang Farmmi Food Co., Ltd., received the Government's municipal-level key agricultural leading enterprise des...

2022-01-06 21:30 2122

JinkoSolar's Subsidiary Jinko Solar Co., Ltd.'s Updated IPO Prospectus and Indicative IPO Timetable Published by the Shanghai Stock Exchange

SHANGRAO, China, Jan. 6, 2022 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, is in the process of applying for an initial public offering ("IPO") of the Company's principal ...

2022-01-06 21:05 4527

I-Mab Announces Senior Management Team Share Purchase Plan

SHANGHAI and GAITHERSBURG, MD., Jan. 6, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the senior management team of the Company, includin...

2022-01-06 21:00 4336

Happiness Development Announces Financial Results for the Six Months Ended September 30, 2021

NANPING, China, Jan. 6, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) aChina-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the s...

2022-01-06 21:00 4106

Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson's and Alzheimer's

MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the United States Patent ...

2022-01-06 20:30 4266

DeepBrain AI grasps attention at CES 2022 with its AI Human imbedded AI Kiosks.

SAN MATEO, Calif., Jan. 6, 2022 /PRNewswire/ -- DeepBrain AI is showcasing its AI Human imbedded "AI Kiosks" fromJanuary 5th to January 7th at CES 2022 held in Las Vegas Convention Center, along with its CES 2022 Innovation Awards honoree SaaS solution "AI Studios". "AI Kiosks" leverages the power...

2022-01-06 20:08 2511

Missfresh Signs 20+ Major Regional Grocery Store Chains To Use Its Retail Cloud Services

BEIJING, Jan. 6, 2022 /PRNewswire/ -- Missfresh Limited ("Missfresh" or the "Company") (NASDAQ: MF), an innovator inChina's neighborhood retail industry, has inked agreements with more than 20 regional supermarket chains to equip more than 150 stores in 19 cities inChi...

2022-01-06 19:30 2884

AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH IVONESCIMAB (PD-1/VEGF BI-SPECIFIC ANTIBODY) COMBINED WITH OR WITHOUT CHEMOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER

HONG KONG, Jan. 6, 2022 /PRNewswire/ -- Today, Akeso, Inc. (09926.HK) announces that Cadonilimab (PD-1/CTLA-4 bi-specific antibody), the  first-inclass novel immuno-oncology drug independently developed by the Company, combined with Ivonescimab (PD-1/VEGF bi-specific antibody), the novel immuno-o...

2022-01-06 19:00 2916

ReneSola Power Closes New Sale of Projects in Poland to Obton

STAMFORD, Conn., Jan. 6, 2022 /PRNewswire/ -- ReneSola Ltd. ("ReneSola Power" or "the Company") (www.renesolapower.com ) (NYSE: SOL), a leading fully integrated solar project developer, today announced that in December, 2021, The Company closed on the sale of 37 MW ...

2022-01-06 19:00 3801

Tuya Smart Introduces Tuya Cube at CES 2022

LAS VEGAS, Jan. 6, 2022 /PRNewswire/ -- Tuya Smart (NYSE: TUYA), a global IoT development platform service provider, unveiled an innovative new solution to the market at CES 2022: Tuya Cube. Tuya Cube offers everything developers need to build their own private IoT platforms with distinctive feat...

2022-01-06 17:50 3469

Dada Group Announces "No Close" During 2022 Chinese New Year

SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- Dada Group (Nasdaq: DADA), China's leading local on-demand delivery and retail platform, today announced its Dada Now and JDDJ platforms, would stay open and continue to offer one-hour on-demand shopping service to consumers across the country during 2022 Ch...

2022-01-06 16:35 2548

Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines

SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- Nuance Pharma ("Nuance"or the "Company"), a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations, today announced an agreement with Sino Health Pharmaceutical Limited ("Sino Health") , an affiliated compa...

2022-01-06 14:45 3907

The 2021-2022 Global Top Brands lists announced - a tribute to China's innovation power

BEIJING, Jan. 6, 2022 /PRNewswire/ -- On January 6, 2022, the 2021-2022 Global Top Brands Awards Ceremony (GTB), co-hosted by Asia Digital Group, Europe Digital Group and TWICE has been held online during the International Consumer Electronics Show (CES). As a key part of CES, the Global Top Bra...

2022-01-06 14:44 2445

Thundercomm Launches New Edge Products at CES 2022

LAS VEGAS, Jan. 5, 2022 /PRNewswire/ -- Thundercomm, the world-leading IoT product and solution provider, enriched its existing edge computing product and solution line-ups today, with three latest strategic products: Edge AI Box EB2, EB6 , and...

2022-01-06 11:50 2929

Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference

SUZHOU, China and ROCKVILLE, Md., Jan. 5, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its participation in and presentation at the 40th A...

2022-01-06 08:30 8067